{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:22:19Z","timestamp":1790418139020,"version":"4.1.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T00:00:00Z","timestamp":1549670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T00:00:00Z","timestamp":1549670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:p>Portal hypertension (PH) is the main driver of cirrhosis decompensation, the main determinant of death in patients with cirrhosis. PH results initially from increased intrahepatic vascular resistance. Subsequently, increased inflow from splanchnic vasodilation and increased cardiac output lead to a further increase in portal pressure (PP). Reducing PP in cirrhosis results in better outcomes. Removing the cause of cirrhosis might improve PP. However, this is a slow process and patients may continue to be at risk of decompensation. Additionally, for some chronic liver diseases, such as nonalcoholic fatty liver disease (NAFLD), etiological treatments are not yet available. Therefore, there is a need to develop better therapies specifically aimed at reducing PP. For over 35 years, the mainstay of such therapy has been the use of nonselective beta\u2010blockers (NSBBs) that act by reducing portal venous inflow. Recently, many drugs (mainly targeting intrahepatic mechanisms) have shown promise in preclinical and early clinical studies and may act alone or synergistically with NSBBs in reducing PP in cirrhosis. The objective of this position paper is to propose a novel framework for the design of clinical trials (phase 1, 2, and 3) in patients with cirrhosis and PH and to prioritize targets and pharmacological therapies in this setting. We have focused the discussion on patients with compensated cirrhosis. The paper summarizes discussions held at The American Association for the Study of Liver Diseases (AASLD) Industry Colloquium in January 2018, with the participation of clinical and translational investigators, regulatory professionals, and industry partners.<\/jats:p>","DOI":"10.1002\/hep.30314","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T08:36:09Z","timestamp":1539592569000},"page":"1287-1299","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":61,"title":["Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension"],"prefix":"10.1097","volume":"69","author":[{"given":"Juan G.","family":"Abraldes","sequence":"first","affiliation":[{"name":"Cirrhosis Care Clinic, Division of Gastroenterology (Liver Unit), Department of Medicine,CEGIIR, University of Alberta,Edmonton,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7028-3881","authenticated-orcid":false,"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[{"name":"Translational Hepatology, Department of Internal Medicine I,University Clinic Frankfurt,Frankfurt,Germany"},{"name":"European Foundation for the Study of Chronic Liver Failure,Institute for Bioengineering of Catalonia,Barcelona,Spain"},{"name":"Faculty of Health Sciences,University of Southern Denmark,Odense,Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga","family":"Chalasani","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Indiana University School of Medicine,Indianapolis,IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"D\u2019Amico","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit,Ospedale V. Cervello,Palermo,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don C.","family":"Rockey","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine,Medical University of South Carolina,Charleston,SC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7620-573X","authenticated-orcid":false,"given":"Vijay H.","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Mayo Clinic,Rochester,MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Bosch","sequence":"additional","affiliation":[{"name":"Swiss Liver Group, University Clinic for Visceral Medicine and Surgery (UVCM),Inselspital, University of Bern,Bern,Switzerland"},{"name":"Hospital Clinic\u2010IDIBAPS and CIBEREHD,University of Barcelona,Barcelona,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Garcia\u2010Tsao","sequence":"additional","affiliation":[{"name":"Digestive Diseases Section,Yale University School of Medicine; VA\u2010CT Healthcare System,New Haven\/West Haven,CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,2,9]]},"reference":[{"key":"hep30314-bib-0001-20241017","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","year":"2007","journal-title":"Gastroenterology"},{"key":"hep30314-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","year":"2015","journal-title":"J Hepatol"},{"issue":"1 Suppl","key":"hep30314-bib-0003-20241017","first-page":"S121","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments","volume":"62","year":"2015","journal-title":"J Hepatol"},{"key":"hep30314-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.28264","article-title":"Development of hyperdynamic circulation and response to beta\u2010blockers in compensated cirrhosis with portal hypertension","volume":"63","year":"2016","journal-title":"Hepatology"},{"key":"hep30314-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","article-title":"Sustained virologic response to interferon\u2010free therapies ameliorates HCV\u2010induced portal hypertension","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"hep30314-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1053\/j.gastro.2017.07.016","article-title":"Effects of all\u2010oral anti\u2010viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus\u2010associated cirrhosis","volume":"153","year":"2017","journal-title":"Gastroenterology"},{"key":"hep30314-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.cgh.2015.04.013","article-title":"Association between severe portal hypertension and risk of liver decompensation in patients with hepatitis C, regardless of response to antiviral therapy","volume":"13","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep30314-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","article-title":"HVPG reduction and prevention of variceal bleeding in cirrhosis. A systematic review","volume":"131","year":"2006","journal-title":"Gastroenterology"},{"key":"hep30314-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2009.03.048","article-title":"Acute hemodynamic response to beta\u2010blockers and prediction of long\u2010term outcome in primary prophylaxis of variceal bleeding","volume":"137","year":"2009","journal-title":"Gastroenterology"},{"key":"hep30314-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/gut.2007.144584","article-title":"Mechanisms of extrahepatic vasodilation in portal hypertension","volume":"57","year":"2008","journal-title":"Gut"},{"key":"hep30314-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2008.12.011","article-title":"Angiogenesis in liver disease","volume":"50","year":"2009","journal-title":"J Hepatol"},{"key":"hep30314-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis and management\u20142016 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"65","year":"2017","journal-title":"Hepatology"},{"key":"hep30314-bib-0013-20241017","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2017.12.027","article-title":"Cardiopulmonary hemodynamics and C\u2010reactive protein as prognostic indicators in compensated and decompensated cirrhosis","volume":"68","year":"2018","journal-title":"J Hepatol"},{"key":"hep30314-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nrgastro.2012.96","article-title":"Recent advances in our understanding of hepatorenal syndrome","volume":"9","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"hep30314-bib-0015-20241017","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1053\/j.gastro.2003.12.007","article-title":"Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis","volume":"126","year":"2004","journal-title":"Gastroenterology"},{"key":"hep30314-bib-0016-20241017","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2009.01.043","article-title":"Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial","volume":"136","year":"2009","journal-title":"Gastroenterology"},{"key":"hep30314-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1053\/j.gastro.2016.01.004","article-title":"Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis","volume":"150","year":"2016","journal-title":"Gastroenterology"},{"key":"hep30314-bib-0018-20241017","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/psp4.39","article-title":"A mechanistic pharmacokinetic model for liver transporter substrates under liver cirrhosis conditions","volume":"4","year":"2015","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"Suppl 7","key":"hep30314-bib-0019-20241017","first-page":"S11","article-title":"Role of hepatic drug transporters in drug development","volume":"56","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"hep30314-bib-0020-20241017","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00003088-200544020-00004","article-title":"The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance","volume":"44","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"hep30314-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1053\/jhep.2001.29306","article-title":"Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts","volume":"34","year":"2001","journal-title":"Hepatology"},{"key":"hep30314-bib-0022-20241017","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.xphs.2017.04.053","article-title":"Effect of liver disease on hepatic transporter expression and function","volume":"106","year":"2017","journal-title":"J Pharm Sci"},{"key":"hep30314-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2165\/00003088-200847110-00005","article-title":"Physiology\u2010based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis","volume":"47","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"hep30314-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"40461","DOI":"10.1038\/srep40461","article-title":"A nitric oxide\u2010donating statin decreases portal pressure with a better toxicity profile than conventional statins in cirrhotic rats","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"hep30314-bib-0025-20241017","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0168-8278(96)80207-8","article-title":"Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites","volume":"25","year":"1996","journal-title":"J Hepatol"},{"key":"hep30314-bib-0026-20241017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0016-5085(79)90268-3","article-title":"Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease","volume":"77","year":"1979","journal-title":"Gastroenterology"},{"key":"hep30314-bib-0027-20241017","article-title":"Nadolol reduces insulin sensitivity in liver cirrhosis: a randomized double\u2010blind crossover trial","volume":"33","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"hep30314-bib-0028-20241017","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1053\/j.gastro.2016.10.010","article-title":"Drug\u2010induced liver injury in patients with preexisting chronic liver disease in drug development: how to identify and manage?","volume":"151","year":"2016","journal-title":"Gastroenterology"},{"key":"hep30314-bib-0029-20241017","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis. A systematic review of 118 studies","volume":"44","year":"2006","journal-title":"J Hepatol"},{"key":"hep30314-bib-0030-20241017","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks","volume":"68","year":"2018","journal-title":"J Hepatol"},{"key":"hep30314-bib-0031-20241017","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jhep.2005.07.036","article-title":"Histological\u2010hemodynamic correlation in cirrhosis\u2010a histological classification of the severity of cirrhosis","volume":"44","year":"2006","journal-title":"J Hepatol"},{"key":"hep30314-bib-0032-20241017","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/jhep.2003.50133","article-title":"Hemodynamic response to pharmacological treatment of portal hypertension and long\u2010term prognosis of cirrhosis","volume":"37","year":"2003","journal-title":"Hepatology"},{"key":"hep30314-bib-0033-20241017","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.20062","article-title":"The hepatic venous pressure gradient: Anything worth doing should be done right","volume":"39","year":"2004","journal-title":"Hepatology"},{"key":"hep30314-bib-0034-20241017","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/hep.28824","article-title":"Anticipate Investigators. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the \u201cAnticipate\u201d study","volume":"64","year":"2016","journal-title":"Hepatology"},{"key":"hep30314-bib-0035-20241017","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta\u2010blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"hep30314-bib-0036-20241017","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1053\/j.gastro.2007.10.028","article-title":"How to prevent varices from bleeding: shades of grey\u2014the case for nonselective beta blockers","volume":"133","year":"2007","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"hep30314-bib-0037-20241017","article-title":"Dynamic prediction of the risk of decompensation\/death in patients with compensated cirrhosis based on serial hepatic venous pressure gradient (HVPG) measurements","volume":"68","year":"2018","journal-title":"Hepatology"},{"key":"hep30314-bib-0038-20241017","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12072-017-9808-z","article-title":"New concepts on the clinical course and stratification of compensated and decompensated cirrhosis","volume":"12","year":"2018","journal-title":"Hepatol Int"},{"key":"hep30314-bib-0039-20241017","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1478-3231.2012.02830.x","article-title":"Prognostic indicators of survival in patients with compensated and decompensated cirrhosis","volume":"32","year":"2012","journal-title":"Liver Int"},{"key":"hep30314-bib-0040-20241017","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/lt.25032","article-title":"Assessment of the spectrum of hepatic encephalopathy: a multicenter study","volume":"24","year":"2018","journal-title":"Liver Transpl"},{"key":"hep30314-bib-0041-20241017","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25\u2010year inception cohort study of 494 patients","volume":"39","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"hep30314-bib-0042-20241017","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/hep.1840110302","article-title":"Agreement among multiple observers on endoscopic diagnosis of esophageal varices before bleeding","volume":"11","year":"1990","journal-title":"Hepatology"},{"key":"hep30314-bib-0043-20241017","article-title":"Beta\u2010blockers to prevent the decompensation of cirrhosis in patients with clinically significant portal hypertension: a randomized, double\u2010blind, placebo\u2010controlled, multicentre trial","year":"2018","journal-title":"Lancet"},{"key":"hep30314-bib-0044-20241017","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.27678","article-title":"Dimick\u2010Santos L; American Association for the Study of Liver Diseases, United States Food and Drug Administration. Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases\u2010U.S. Food and Drug Administration Joint Workshop","volume":"61","year":"2015","journal-title":"Hepatology"},{"key":"hep30314-bib-0045-20241017","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/gast.1996.v111.pm8780575","article-title":"Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10\u2010year prospective study","volume":"111","year":"1996","journal-title":"Gastroenterology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.30314","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201903000-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T23:36:54Z","timestamp":1729208214000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201903000-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,9]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.30314","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,9]]},"assertion":[{"value":"2018-06-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}